Syneos Health, Inc. Class A Common Stock
SYNH
SYNH was delisted on the 27th of September, 2023.
305 hedge funds and large institutions have $3.69B invested in Syneos Health, Inc. Class A Common Stock in 2023 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 113 increasing their positions, 105 reducing their positions, and 47 closing their positions.
83% more call options, than puts
Call options by funds: $6.17M | Put options by funds: $3.37M
8% more repeat investments, than reductions
Existing positions increased: 113 | Existing positions reduced: 105
2% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 47
1% less funds holding
Funds holding: 307 → 305 (-2)
1% less capital invested
Capital invested by funds: $3.73B → $3.69B (-$33.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$90.7M |
| 2 |
D.E. Shaw & Co
New York
|
+$47.8M |
| 3 |
EARNEST Partners
Atlanta,
Georgia
|
+$39.7M |
| 4 |
SC
Sessa Capital
New York
|
+$33.1M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$27.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$111M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$106M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$86M |
| 4 |
CB
Cooke & Bieler
Philadelphia,
Pennsylvania
|
-$69.1M |
| 5 |
Amundi
Paris,
France
|
-$23.9M |
SYNH Hedge Fund Activity: Q1 2023 in Review
305 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Syneos Health, Inc. Class A Common Stock (SYNH) for Q1 2023, worth a combined $3.69B — down 0.89% from $3.73B a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new SYNH positions and 47 closed out — a net gain of 1 holder — while 113 added to existing stakes and 105 trimmed.
The largest buyer was Barclays, adding an estimated $90.7M. The largest seller was Goldman Sachs, cutting an estimated $111M.
- 305 institutional investors held Syneos Health, Inc. Class A Common Stock (SYNH) as of Q1 2023, down from 307 in Q4 2022.
- Funds reported $3.69B of Syneos Health, Inc. Class A Common Stock stock for Q1 2023, down 0.89% quarter-over-quarter.
- 48 funds opened new Syneos Health, Inc. Class A Common Stock positions in Q1 2023 and 47 closed out, a net change of +1 holder.
- The largest Syneos Health, Inc. Class A Common Stock buyer in Q1 2023 was Barclays, an estimated $90.7M added.
- The largest Syneos Health, Inc. Class A Common Stock seller in Q1 2023 was Goldman Sachs, an estimated $111M sold.
Based on aggregated 13F filings for Q1 2023.